These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1098444)

  • 1. Letter: Antinuclear antibodies-clinical significance of the nuclear immunofluorescent patterns.
    Burnham TK; Bank PW
    Am J Clin Pathol; 1975 Aug; 64(2):289-90. PubMed ID: 1098444
    [No Abstract]   [Full Text] [Related]  

  • 2. The immunofluorescent tumor imprint technic. 3. The diagnostic and prognostic significance of the "speckle"-inducing antinuclear antibody.
    Burnham TK; Neblett TR; Fine G
    Am J Clin Pathol; 1968 Dec; 50(6):683-8. PubMed ID: 4881946
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of anticentromere antibody assay].
    Moteki S
    Nihon Rinsho; 1990 Feb; 48 Suppl():580-3. PubMed ID: 2192153
    [No Abstract]   [Full Text] [Related]  

  • 4. [Raynaud disease].
    Pettersson T
    Duodecim; 2005; 121(22):2411-9. PubMed ID: 16457072
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: A simple immunofluorescence method for differentiation of ANF between RA and healthy persons and SLE and scleroderma patients.
    Stojan B
    Ann Rheum Dis; 1975 Apr; 34(2):197-8. PubMed ID: 1094966
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clues for previously undiagnosed connective tissue disease in patients with trigeminal neuralgia.
    Nascimento IS; Bonfá E; de Carvalho JF; Saad CG; Vendramini MB; Teixeira MJ; Nóbrega JC; Viana VS
    J Clin Rheumatol; 2010 Aug; 16(5):205-8. PubMed ID: 20661065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence.
    Burnham TK; Neblett TR; Fine G; Bank P
    Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T; Kahn MF; Peltier AP; de SEZE S
    Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined titre and fluorescent pattern of IgG antinuclear antibodies using cultured cell monolayers in evaluating connective tissue diseases.
    Parker MD; Kerby GP
    Ann Rheum Dis; 1974 Sep; 33(5):465-72. PubMed ID: 4608364
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of human antinuclear antibodies on rodent omenta.
    Holub M
    Allerg Immunol (Leipz); 1982; 28(2):118-21. PubMed ID: 6182782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current immunological diagnosis of collagenoses. I. Systemic lupus erythematosus and systemic scleroderma].
    Jarzabek-Chorzelska M; Kołacińska-Strasz Z; Błaszczyk M; Chorzelski T; Jabłońska S
    Przegl Dermatol; 1987; 74(6):421-30. PubMed ID: 3330246
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic lupus erythematosus in children and adolescents.
    Gottlieb BS; Ilowite NT
    Pediatr Rev; 2006 Sep; 27(9):323-30. PubMed ID: 16950937
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of antinuclear antibodies in overlap syndromes. I. Relationship between systemic lupus erythematosus, diffuse scleroderma and dermatomyositis].
    Zitnan D; Rovenský J; Cebecauer L; Hajzok O
    Fysiatr Revmatol Vestn; 1973 Jun; 51(3):152-7. PubMed ID: 4592583
    [No Abstract]   [Full Text] [Related]  

  • 16. Coexistence of lupus erythematosus and scleroderma in light of immunopathological investigations.
    Chorzelski T; Jablónska S
    Acta Derm Venereol; 1970; 50(2):81-5. PubMed ID: 4192323
    [No Abstract]   [Full Text] [Related]  

  • 17. Disease distributions in patients with multiple patterns of nuclear staining detected by FANA (immunofluorescent antinuclear antibody) tests.
    Rothberger H; Lee TK; Wise C
    Clin Exp Rheumatol; 1986; 4(3):201-7. PubMed ID: 3533338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apropos of "borderline" connective tissue diseases. Visceral lupus and scleroderma].
    Cayla J; Saporta L; Delbarre F; Coste F
    Bull Mem Soc Med Hop Paris; 1967 Apr; 118(7):681-97. PubMed ID: 4170418
    [No Abstract]   [Full Text] [Related]  

  • 19. [Detection of antinuclear antibodies using HEp-2 cells as nuclear substrates by the indirect immunofluorescent antibody technic].
    Watanabe S; Miyawaki S
    Rinsho Byori; 1987 Jan; 35(1):61-6. PubMed ID: 3550177
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relation between capillary microscopy parameters and clinico-serologic data in patients with systemic lupus erythematosus].
    Caspary L; Schoetensack I; Schmees C; Hartung K; Stannat S; Creutzig A; Deicher H; Alexander K
    Vasa Suppl; 1991; 32():233-5. PubMed ID: 1771503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.